# ISORX CYCLOTRON CENTER – FDA Inspection, Mar 20, 2025

Source: https://www.keypedia.com/records/fda_inspections/isorx-cyclotron-center/acb95493-b2ab-4b18-a36c-ed6168464e55
Source feed: FDA_Inspections

> FDA inspection 1264258 of ISORX CYCLOTRON CENTER, March 20, 2025. Classification: Official Action Indicated (OAI). 6 citations under 21 CFR part 212. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1264258
- Company Name: ISORX CYCLOTRON CENTER
- Inspection Date: 2025-03-20
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Generic Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Dallas District Office
- Citation Count: 6

## Related Documents

- [FDA Inspection 1307106 - 2026-03-13](https://www.keypedia.com/records/fda_inspections/isorx-cyclotron-center/af840374-ff22-415a-84c2-98e6b3dddedd)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/camerson-e-moore/50733244-0d55-4b0b-a758-f192b7c66457)

Company: https://www.keypedia.com/companies/isorx-cyclotron-center/a96b7742-c699-4b8b-ab67-9bf281830698

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9
